BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30390338)

  • 1. Prognostic value of a two-microRNA signature for papillary thyroid cancer and a bioinformatic analysis of their possible functions.
    Liu T; You X; Sui J; Shen B; Zhang Y; Zhang XM; Yang S; Yao YZ; Yang F; Yin LH; Pu YP; Liang GY
    J Cell Biochem; 2019 May; 120(5):7185-7198. PubMed ID: 30390338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA signature predicts survival in papillary thyroid carcinoma.
    Chengfeng X; Gengming C; Junjia Z; Yunxia L
    J Cell Biochem; 2019 Oct; 120(10):17050-17058. PubMed ID: 31099134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive MicroRNA expression profiling identifies novel markers in follicular variant of papillary thyroid carcinoma.
    Dettmer M; Perren A; Moch H; Komminoth P; Nikiforov YE; Nikiforova MN
    Thyroid; 2013 Nov; 23(11):1383-9. PubMed ID: 23427895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomal hsa-miR-129-2 and hsa-miR-889 from a 6-microRNA Signature Might be a Potential Biomarker for Predicting the Prognosis of Papillary Thyroid Carcinoma.
    Xin Y; Meng K; Guo H; Chen B; Zheng C; Shou X; Yu K
    Comb Chem High Throughput Screen; 2022; 25(5):819-830. PubMed ID: 33550967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder.
    Inamoto T; Uehara H; Akao Y; Ibuki N; Komura K; Takahara K; Takai T; Uchimoto T; Saito K; Tanda N; Yoshikawa Y; Minami K; Hirano H; Nomi H; Kato R; Hayashi T; Azuma H
    Dis Markers; 2018; 2018():5468672. PubMed ID: 30026881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Five-microRNA Signature as Prognostic Biomarker in Colorectal Cancer by Bioinformatics Analysis.
    Yang G; Zhang Y; Yang J
    Front Oncol; 2019; 9():1207. PubMed ID: 31799184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma.
    Zhang X; Ma L; Zhai L; Chen D; Li Y; Shang Z; Zhang Z; Gao Y; Yang W; Li Y; Pan Y
    Int J Med Sci; 2021; 18(4):984-999. PubMed ID: 33456356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a four-miRNA signature predicts the prognosis of papillary thyroid cancer.
    Yang F; Zhou YL
    World J Clin Cases; 2023 Jan; 11(1):92-103. PubMed ID: 36687184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinformatic analysis and
    Li W; Kong X; Huang T; Shen L; Wu P; Chen QF
    Ann Transl Med; 2020 Nov; 8(21):1422. PubMed ID: 33313167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BCL2 and hsa-miR-181a-5p are potential biomarkers associated with papillary thyroid cancer based on bioinformatics analysis.
    Zhang C; Bo C; Guo L; Yu P; Miao S; Gu X
    World J Surg Oncol; 2019 Dec; 17(1):221. PubMed ID: 31842912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated microRNA, gene expression and transcription factors signature in papillary thyroid cancer with lymph node metastasis.
    Ab Mutalib NS; Othman SN; Mohamad Yusof A; Abdullah Suhaimi SN; Muhammad R; Jamal R
    PeerJ; 2016; 4():e2119. PubMed ID: 27350898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of papillary thyroid carcinoma: a potential three-lncRNA prognostic signature.
    You X; Yang S; Sui J; Wu W; Liu T; Xu S; Cheng Y; Kong X; Liang G; Yao Y
    Cancer Manag Res; 2018; 10():4297-4310. PubMed ID: 30349364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Necroptosis-Related miRNA Signature for Predicting the Prognosis of Breast Cancer Metastasis.
    Zheng L; Wang J; Jiang H; Dong H
    Dis Markers; 2022; 2022():3391878. PubMed ID: 35371342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the miRNA signature and key genes in colorectal cancer lymph node metastasis.
    Wang X; Gao G; Chen Z; Chen Z; Han M; Xie X; Jin Q; Du H; Cao Z; Zhang H
    Cancer Cell Int; 2021 Jul; 21(1):358. PubMed ID: 34315491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined identification of three miRNAs in serum as effective diagnostic biomarkers for HNSCC.
    Liu C; Yu Z; Huang S; Zhao Q; Sun Z; Fletcher C; Jiang Y; Zhang D
    EBioMedicine; 2019 Dec; 50():135-143. PubMed ID: 31780396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioinformatics Analysis of a Prognostic miRNA Signature and Potential Key Genes in Pancreatic Cancer.
    Chen S; Gao C; Yu T; Qu Y; Xiao GG; Huang Z
    Front Oncol; 2021; 11():641289. PubMed ID: 34094925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying a new microRNA signature as a prognostic biomarker in colon cancer.
    Lv Y; Duanmu J; Fu X; Li T; Jiang Q
    PLoS One; 2020; 15(2):e0228575. PubMed ID: 32049961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of a molecular risk model for the prognosis of cervical cancer based on microRNA expression.
    Li J; Liang L; Xiu L; Zeng J; Zhu Y; An J; Wu L
    Ann Transl Med; 2022 Jan; 10(2):125. PubMed ID: 35282101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
    Zhang C; Zhang CD; Ma MH; Dai DQ
    World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microarray profiling of circular RNAs in human papillary thyroid carcinoma.
    Peng N; Shi L; Zhang Q; Hu Y; Wang N; Ye H
    PLoS One; 2017; 12(3):e0170287. PubMed ID: 28288173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.